- AD5-nCOV, trade-named
Convidecia, is a single-dose
viral vector vaccine for COVID-19 that is also used as an
inhaled booster. It was
developed by CanSino...
- Oxford–AstraZeneca,
Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax,
Convidecia, and Sanofi–GSK.
Seven others are
under ****essment by the WHO: Sputnik...
-
which had
cancelled CanSino's
contract with
Canada for its
COVID vaccine,
Convidecia.
Poilievre insisted that
Canada should create its own
vaccine supply and...
- US
Vaccine card
Vaccine p****ports
Current vaccines CoronaVac Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm...
-
vaccines were two-dose vaccines, with the
exception single-dose
vaccines Convidecia and the
Janssen COVID‑19 vaccine, and
vaccines with three-dose schedules...
- US
Vaccine card
Vaccine p****ports
Current vaccines CoronaVac Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm...
-
Products Administration granted approval for the
Convidecia Air, an
inhaled version of the
Convidecia vaccine, to be used as a
booster dose.
China - In...
-
viral vector vaccines:
Sputnik Light,
Sputnik V, Oxford–AstraZeneca,
Convidecia, Janssen, and
iNCOVACC sixteen subunit vaccines: Abdala, Corbevax, COVAX-19...
- COVID-19 pandemic, the AMMS
partnered with
CanSino Biologics to
develop Convidecia. The
development team, led by Chen Wei,
registered a
Phase 1
trial in...
- US
Vaccine card
Vaccine p****ports
Current vaccines CoronaVac Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm...
